ME01273B - Upotreba 4-ciklopropilmetoksi-n-(3,5-dihloro-1- oksidopiridin-4- il)-5-(metoksi)piridin-2-karboksamida za liječenje povreda lobanje - Google Patents

Upotreba 4-ciklopropilmetoksi-n-(3,5-dihloro-1- oksidopiridin-4- il)-5-(metoksi)piridin-2-karboksamida za liječenje povreda lobanje

Info

Publication number
ME01273B
ME01273B MEP-2012-15A MEP1512A ME01273B ME 01273 B ME01273 B ME 01273B ME P1512 A MEP1512 A ME P1512A ME 01273 B ME01273 B ME 01273B
Authority
ME
Montenegro
Prior art keywords
cyclopropylmethoxy
carboxamide
dichloro
pyridine
methoxy
Prior art date
Application number
MEP-2012-15A
Other languages
English (en)
Inventor
Philippe Delay-Goyet
Corinne Perron
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38819821&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01273(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ME01273B publication Critical patent/ME01273B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Upotreba 4-ciklopropilmetoksi-N-(3,5-dihloro-1-oksido-piridin-4-il)-5-(metoksi)piridin-2- karboksamida, u vidu hidrata, solvata, baze ili adicione soli neke kisjeline za dobijanje nekog lijeka namijenjenog tretmanu cerebralnih povreda. Patent sadrži još 1 patentni zahtjev.
MEP-2012-15A 2007-04-19 2008-04-16 Upotreba 4-ciklopropilmetoksi-n-(3,5-dihloro-1- oksidopiridin-4- il)-5-(metoksi)piridin-2-karboksamida za liječenje povreda lobanje ME01273B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0702852A FR2915099B1 (fr) 2007-04-19 2007-04-19 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
EP08787960A EP2146713B1 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
PCT/FR2008/000531 WO2008145838A2 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens

Publications (1)

Publication Number Publication Date
ME01273B true ME01273B (me) 2013-06-20

Family

ID=38819821

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2012-15A ME01273B (me) 2007-04-19 2008-04-16 Upotreba 4-ciklopropilmetoksi-n-(3,5-dihloro-1- oksidopiridin-4- il)-5-(metoksi)piridin-2-karboksamida za liječenje povreda lobanje
MEP-2009-306A ME00938B (me) 2007-04-19 2008-04-16 UPOTREBA 4-CIKLOPROPILMETOKSI-n-(3,5-DIHLORO-1-OKSIDO-4-PIRIDIN-4-YL)-5-(METOKSI)PIRIDIN-2-KARBOKSAMIDA U TRETIRANJU KRANIJALNIH TRAUMATIZAMA

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2009-306A ME00938B (me) 2007-04-19 2008-04-16 UPOTREBA 4-CIKLOPROPILMETOKSI-n-(3,5-DIHLORO-1-OKSIDO-4-PIRIDIN-4-YL)-5-(METOKSI)PIRIDIN-2-KARBOKSAMIDA U TRETIRANJU KRANIJALNIH TRAUMATIZAMA

Country Status (34)

Country Link
US (1) US9393236B2 (me)
EP (1) EP2146713B1 (me)
JP (1) JP5386476B2 (me)
KR (1) KR101460828B1 (me)
CN (1) CN101663036B (me)
AR (1) AR066105A1 (me)
AT (1) ATE532513T1 (me)
AU (1) AU2008257319B2 (me)
BR (1) BRPI0810423A2 (me)
CA (1) CA2684171C (me)
CL (1) CL2008001135A1 (me)
CO (1) CO6140028A2 (me)
CY (1) CY1112282T1 (me)
DK (1) DK2146713T3 (me)
EA (1) EA015503B1 (me)
ES (1) ES2376023T3 (me)
FR (1) FR2915099B1 (me)
HK (1) HK1141724A1 (me)
HR (1) HRP20120130T1 (me)
IL (1) IL201447A (me)
JO (1) JO2861B1 (me)
MA (1) MA31368B1 (me)
ME (2) ME01273B (me)
MX (1) MX2009011214A (me)
MY (1) MY147207A (me)
NZ (1) NZ580484A (me)
PA (1) PA8776701A1 (me)
PL (1) PL2146713T3 (me)
PT (1) PT2146713E (me)
RS (1) RS52130B (me)
SI (1) SI2146713T1 (me)
TW (1) TWI423800B (me)
UY (1) UY31034A1 (me)
WO (1) WO2008145838A2 (me)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015006807A (es) * 2012-11-28 2016-01-14 Sanofi Sa Metodo de preparacion de formas cristalinas de la 4-(ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metox ipiridin-2-carboxamida y sus formas cristalinas.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1273326A (en) * 1917-08-22 1918-07-23 George H Bugenhagen Transmission mechanism.
US4193926A (en) * 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
ATE218549T1 (de) * 1993-07-28 2002-06-15 Aventis Pharma Ltd Verbindungen als pde iv und tnf inhibitoren
GB9401460D0 (en) * 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
GB9507297D0 (en) * 1995-04-07 1995-05-31 Rh Ne Poulenc Rorer Limited New composition of matter
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
PL357340A1 (en) * 1999-06-07 2004-07-26 Warner-Lambert Company Tricyclic analgesics
ES2239063T3 (es) * 1999-12-23 2005-09-16 Icos Corporation Inhibidores de la fosfodiesterasa ciclica especifica de amp.
US20030069169A1 (en) * 2001-03-02 2003-04-10 Macor John E. Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders
WO2004005258A1 (en) 2002-07-02 2004-01-15 Merck Frosst Canada & Co. Di-aryl-substituted-ethane pyridone pde4 inhibitors
US20060083714A1 (en) * 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
EP1685109A2 (en) 2003-10-07 2006-08-02 Renovis, Inc. Amide compounds as ion channel ligands and uses thereof
US20070049611A1 (en) * 2005-06-10 2007-03-01 Talamas Francisco X Phosphodiesterase 4 inhibitors
US20070021451A1 (en) * 2005-07-20 2007-01-25 Hamamatsu University School Of Medicine Method for preventing or treating neurologic damage after spinal cord injury
FR2915098B1 (fr) 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere

Also Published As

Publication number Publication date
CA2684171C (fr) 2015-12-01
TW200914009A (en) 2009-04-01
FR2915099B1 (fr) 2009-06-05
TWI423800B (zh) 2014-01-21
DK2146713T3 (da) 2012-03-05
JO2861B1 (en) 2015-03-15
US9393236B2 (en) 2016-07-19
RS52130B (en) 2012-08-31
AU2008257319A1 (en) 2008-12-04
EA200970968A1 (ru) 2010-02-26
CY1112282T1 (el) 2015-12-09
EP2146713B1 (fr) 2011-11-09
ME00938B (me) 2012-06-20
PL2146713T3 (pl) 2012-04-30
WO2008145838A3 (fr) 2009-03-26
US20100130553A1 (en) 2010-05-27
EA015503B1 (ru) 2011-08-30
ES2376023T3 (es) 2012-03-08
JP5386476B2 (ja) 2014-01-15
HRP20120130T1 (hr) 2012-03-31
FR2915099A1 (fr) 2008-10-24
SI2146713T1 (sl) 2012-03-30
CN101663036B (zh) 2012-06-20
HK1141724A1 (me) 2010-11-19
CL2008001135A1 (es) 2009-01-16
CO6140028A2 (es) 2010-03-19
JP2010524903A (ja) 2010-07-22
PA8776701A1 (es) 2008-11-19
MY147207A (en) 2012-11-14
KR20090130058A (ko) 2009-12-17
UY31034A1 (es) 2008-11-28
EP2146713A2 (fr) 2010-01-27
CA2684171A1 (fr) 2008-12-04
BRPI0810423A2 (pt) 2014-10-14
IL201447A0 (en) 2010-05-31
KR101460828B1 (ko) 2014-11-11
AR066105A1 (es) 2009-07-22
AU2008257319B2 (en) 2013-07-25
MA31368B1 (fr) 2010-05-03
MX2009011214A (es) 2009-11-02
IL201447A (en) 2013-07-31
NZ580484A (en) 2011-06-30
CN101663036A (zh) 2010-03-03
PT2146713E (pt) 2012-02-07
WO2008145838A2 (fr) 2008-12-04
ATE532513T1 (de) 2011-11-15

Similar Documents

Publication Publication Date Title
UA108222C2 (xx) СПОЛУКИ ЗАМІЩЕНОГО N-(1H-ІНДАЗОЛ-4-ІЛ)ІМІДАЗОЛ$1,2-а]ПІРИДИН-3-КАРБОКСАМІДУ ЯК ІНГІБІТОРИ cFMS
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
MX2020012868A (es) Metodos y composiciones para trastornos del sue?o y otros trastornos.
ECSP109953A (es) Derivados de piridazinona
ATE469158T1 (de) Heteroalkylgebundene pyrimidinderivate
IL211825A (en) Compounds based on pyridine and pyrimidine for use as wnt signal transducer inhibitors, pharmaceutical formulations containing such compounds and used as drugs for the treatment and / or cancer prevention
MX2009008253A (es) Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
NO20072558L (no) Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav
WO2010038086A3 (en) P38 map kinase inhibitors
BRPI0813625A2 (pt) Imidazo-[1,2b]-piridozinas 2,3,7-substituídos para tratamento de doenças mediadas por alzk4 ou alk5
MX2011012353A (es) Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2, 3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de la cinasa janus.
IL200793A0 (en) Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases
MA32272B1 (fr) Inhibiteurs de raf de pyrazole [3,4-b]pyridine
EA201001242A1 (ru) ПИРРОЛО[2,3-d]ПИРИДИНЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИНКИНАЗЫ
ECSP10010361A (es) Derivados de piridazinona
SI2176252T1 (sl) 2,3-dihidrobenzo(1,4)dioksin-2-ilmetilni derivati kot alfa2C antagonisti za uporabo v zdravljenju bolezni perifernega in centralnega živčnega sistema
ATE542814T1 (de) Pyrazinkinaseinhibitoren
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
MY146403A (en) F, g, h, i and k crystal forms of imatinib mesylate
DE602006017574D1 (de) Als protein-kinase-inhibitoren nutzbare benzimidazole
UA99485C2 (ru) Хиназолиндионовые производные, их получение и их применение в терапии
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
MY150098A (en) Benzylpiperazine derivates and their medical use
TW200738723A (en) 1-(1-(2-Ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and salts thereof
HRP20110459T1 (hr) Upotreba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju ozljeda kralježnične moždine